PR NewswireDALLAS, April 28, 2025
Proactive security with AI-powered model built for modern enterprise workloadsDALLAS, April 28, 2025 /PRNewswire/ -- Tren
Nouveau Monde Graphite Inc. (”NMG” or the ”Company”) ([url="]NYSE: NMG[/url], [url="]TSX: NOU[/url]) issues the results of the Updated Technical Feasib
FDA Accepts LEQEMBI ® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease
China's National Medical Products Administration (NMPA) Approves PADCEV™ in combination with KEYTRUDA ® (pembrolizumab) for the Treatment of Advanced Bladder Cancer